These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 18067048

  • 1. Calcium channels blockers and progression of kidney disease.
    Ziakka S, Kaperonis N, Ferentinou E, Karakasis F, Ntatsis G, Kourvelou C, Papagalanis N.
    Ren Fail; 2007; 29(8):1003-12. PubMed ID: 18067048
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease.
    Abe M, Okada K, Maruyama T, Maruyama N, Matsumoto K.
    Hypertens Res; 2009 Apr; 32(4):270-5. PubMed ID: 19262495
    [Abstract] [Full Text] [Related]

  • 3. Effects of combination therapy with angiotensin II type I receptor blockers and calcium channel blockers on renal function in hypertensive patients/a retrospective, "real-world" comparative study.
    Yamada H, Suga N, Maeda K, Kimura Y, Miura N, Futenma A, Imai H.
    Arzneimittelforschung; 2010 Apr; 60(2):64-70. PubMed ID: 20329653
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Management of hypertension in CKD patients].
    Kusaba T, Kimura K.
    Nihon Rinsho; 2008 Sep; 66(9):1747-52. PubMed ID: 18788405
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Verapamil versus amlodipine in proteinuric non-diabetic nephropathies treated with trandolapril (VVANNTT study): design of a prospective randomized multicenter trial.
    Boero R, Rollino C, Massara C, Vagelli G, Gonella M, Berto IM, Bajardi P, Perosa P, Malcangi U, Giorgi MP, Ghezzi PM, Borzumati M, Baroni AM, Cogno C, Triolo G, Angelini D, Antonelli A, Quarello F.
    J Nephrol; 2001 Sep; 14(1):15-8. PubMed ID: 11281338
    [Abstract] [Full Text] [Related]

  • 12. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
    Yang Y, Wei RB, Xing Y, Tang L, Zheng XY, Wang ZC, Gao YW, Li MX, Chen XM.
    Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
    [Abstract] [Full Text] [Related]

  • 13. Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN).
    Ruggenenti P, Perna A, Benini R, Remuzzi G.
    J Am Soc Nephrol; 1998 Nov; 9(11):2096-101. PubMed ID: 9808096
    [Abstract] [Full Text] [Related]

  • 14. Influence of T-calcium channel blocker treatment on deterioration of renal function in chronic kidney disease.
    Omae K, Ogawa T, Nitta K.
    Heart Vessels; 2009 Jul; 24(4):301-7. PubMed ID: 19626404
    [Abstract] [Full Text] [Related]

  • 15. Renoprotective effect and cost-effectiveness of using benidipine, a calcium channel blocker, to lower the dose of angiotensin receptor blocker in hypertensive patients with albuminuria.
    Saito F, Fujita H, Takahashi A, Ichiyama I, Harasawa S, Oiwa K, Takahashi N, Otsuka Y, Uchiyama T, Kanmatsuse K, Kushiro T.
    Hypertens Res; 2007 Jan; 30(1):39-47. PubMed ID: 17460370
    [Abstract] [Full Text] [Related]

  • 16. Renal and cardiovascular effects of angiotensin-converting enzyme inhibitor plus angiotensin II receptor antagonist therapy in children with proteinuria.
    Lubrano R, Soscia F, Elli M, Ventriglia F, Raggi C, Travasso E, Scateni S, Di Maio V, Versacci P, Masciangelo R, Romero S.
    Pediatrics; 2006 Sep; 118(3):e833-8. PubMed ID: 16923922
    [Abstract] [Full Text] [Related]

  • 17. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 18. Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
    Ishimitsu T, Kameda T, Akashiba A, Takahashi T, Ohta S, Yoshii M, Minami J, Ono H, Numabe A, Matsuoka H.
    Hypertens Res; 2007 Jul 20; 30(7):621-6. PubMed ID: 17785930
    [Abstract] [Full Text] [Related]

  • 19. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
    Zhao HJ, Li Y, Liu SM, Sun XG, Li M, Hao Y, Cui LQ, Wang AH.
    Ren Fail; 2016 Jul 20; 38(6):849-56. PubMed ID: 27055479
    [Abstract] [Full Text] [Related]

  • 20. Slowing nephropathy progression: focus on proteinuria reduction.
    Bakris GL.
    Clin J Am Soc Nephrol; 2008 Jan 20; 3 Suppl 1(Suppl 1):S3-10. PubMed ID: 18178794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.